Thermo Fisher Scientific Inc. completed the €90 million acquisition of a Cork, Ireland-based manufacturing facility from GlaxoSmithKline PLC following regulatory approvals.
Waltham, Mass.-based Thermo Fisher said in an Oct. 1 press release that the site — which employs about 400 people — will become part of Thermo Fisher's Pharma Services business within its Laboratory Products and Services segment.
The facility produces specialized active pharmaceutical ingredients for treating diseases that include childhood cancer, depression and Parkinson's. Under a multiyear supply agreement, Thermo Fisher will continue to produce pharmaceutical ingredients for U.K.-based GlaxoSmithKline and also expects to expand the use of the site to develop ingredients for other customers.
